Egetis Therapeutics AB (publ) (EGTX) — Financial Flexibility Index
Egetis Therapeutics AB (publ) (EGTX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of Skr-64.30 Million (operating CF Skr-64.30 Million minus capex Skr0.00) represents 0% of total liabilities (Skr288.70 Million). Check Egetis Therapeutics AB (publ) total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Egetis Therapeutics AB (publ) Financial Flexibility Index (2010–2025)
Historical Financial Flexibility Index trend for Egetis Therapeutics AB (publ) across 16 annual periods. For the full cash flow conversion analysis, see Egetis Therapeutics AB (publ) cash conversion from operations.
Annual Financial Flexibility Index for Egetis Therapeutics AB (publ) (2010–2025)
Year-by-year free cash flow to debt coverage for Egetis Therapeutics AB (publ). Explore EGTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | Skr-265.60 Million | Skr-267.10 Million | Skr300.40 Million | ▼ -16.2% |
| 2024 | -0.76x | Skr-227.90 Million | Skr-227.90 Million | Skr299.40 Million | ▲ +41.3% |
| 2023 | -1.30x | Skr-278.40 Million | Skr-278.40 Million | Skr214.60 Million | ▲ +59.0% |
| 2022 | -3.16x | Skr-173.50 Million | Skr-173.50 Million | Skr54.90 Million | ▼ -2.7% |
| 2021 | -3.08x | Skr-129.94 Million | Skr-130.11 Million | Skr42.23 Million | ▼ -504.2% |
| 2020 | -0.51x | Skr-134.62 Million | Skr-134.64 Million | Skr264.34 Million | ▲ +79.5% |
| 2019 | -2.49x | Skr-62.62 Million | Skr-62.64 Million | Skr25.20 Million | ▲ +29.8% |
| 2018 | -3.54x | Skr-80.29 Million | Skr-80.31 Million | Skr22.68 Million | ▲ +52.3% |
| 2017 | -7.42x | Skr-86.53 Million | Skr-86.55 Million | Skr11.66 Million | ▼ -41.3% |
| 2016 | -5.25x | Skr-36.12 Million | Skr-36.12 Million | Skr6.87 Million | ▲ +55.5% |
| 2015 | -11.82x | Skr-51.15 Million | Skr-51.15 Million | Skr4.33 Million | ▼ -265.8% |
| 2014 | -3.23x | Skr-41.38 Million | Skr-41.38 Million | Skr12.81 Million | ▲ +53.3% |
| 2013 | -6.92x | Skr-28.07 Million | Skr-28.07 Million | Skr4.06 Million | ▼ -41.1% |
| 2012 | -4.90x | Skr-31.96 Million | Skr-31.96 Million | Skr6.52 Million | ▼ -283.2% |
| 2011 | -1.28x | Skr-4.98 Million | Skr-14.40 Million | Skr3.89 Million | ▼ -307.2% |
| 2010 | -0.31x | Skr-472.28K | Skr-2.72 Million | Skr1.50 Million | — |